Doctoral Researcher in Molecular Biology of Transcription
Dr Harri M. Itkonen’s research group at the Faculty of Medicine, University of Helsinki, invites applications for the position of
DOCTORAL RESEARCHER (PhD Trainee)
We are looking for a creative thinker with demonstrated competence in bioinformatics, who has high motivation to develop novel therapies to treat cancer. The applicant should be familiar with command-line based tools used in Linux. Of equal importance is the candidate’s willingness to either already possess, or, alternatively, willingness, to learn molecular biology. Alternatively, applications from MSc-graduates with excellent skills in molecular biology are also invited.
Our research
We study the rewiring of transcriptional networks in cancer cells, and how this rewiring could be exploited as a basis for cancer therapy. The major disease model of interest is prostate cancer, and particularly the aggressive forms of this disease, which do not respond well to the existing therapies. Our scientific interest is broadly in the feedback relationships between external cues and chromatin/transcription.
The Team currently consists of the principal investigator, three PhD Trainees, two post-PhD researchers, and one MSc-Trainee. Our projects are structured to probe both ambitious but also more straightforward projects, which assures that my PhD Trainees graduate in 3-4 years with first author publications that enable progression to the next stage in their careers. We have expertise in both bioinformatics and molecular biology, and we are well-connected internationally. These aspects ensure that the hired PhD Trainee will have both support and also chance to present her / his findings both internally but also in international meetings.
We utilize a wide range of techniques including cell biology, organoid technology, live-cell imaging, mass spectrometry, ChIP-, SLAM- and RNA-seq among others to study processes that cancer cells are addicted to (see eg. Chatterjee & al. (2026) Molecular Oncology, Gondane & al. (2025) Journal of Biomedical Science; Yalala & al (2024) FASEB, Gondane & al. (2022) Journal of Biomedical Science; Hu & al. (2021) RNA Biology, Itkonen & al. Mol Cancer Res (2020)). Our previous studies lay the foundation on future research.
Radiation therapy (RT) is the cornerstone of cancer management as it is safe and effective, and it is frequently used as part of therapy against the most common cancer in men, prostate cancer. Despite being both safe and effective, in a large number of cases, it is not curative. In addition, RT comes often with significant negative side effects, and it is not understood why certain tumours respond strongly to this therapy while others fail to respond.
In the current project, we use both cancer cell lines and patient-derived cancer models that incorporate the immune system. Our goal is to develop biomarkers that predict sensitivity to RT and also identify correct combinatorial therapies to augment its efficacy. In brief, we aim to turn one of the most widely used therapies to control cancer, RT, into a curative one for a large number of patients.
You can find more information on our Team and projects from the laboratory’s web page:
https://www.helsinki.fi/en/researchgroups/transcriptional-rewiring-cancer
Your qualifications
The PhD candidate must hold, or soon receive, an MSc degree, and have background in bioinformatics and / or molecular biology. Strong written and oral communication skills in English are a must. Experience in one of the following methodologies: human cell culture, RNA biology, ChIP- / RNA-sequencing is expected. Candidates are requested to familiarize themselves with the literature (see section ‘Our research’).
The appointee must apply for the right to pursue a doctoral degree at the University of Helsinki within the probationary period of six months of their appointment. Please, see: www.helsinki.fi/en/research/doctoral-education/the-application-process-in-a-nutshell. The requirements for pursuing a doctoral degree at the University of Helsinki can be found at https://www.helsinki.fi/en/research/doctoral-education/eligibility-and-educational-documents. The chosen applicant is expected to reside in Finland while employed by the University of Helsinki, and the position may include additional research visits to abroad.
What we offer
Employment is expected to start in spring 2027 as agreed for a fixed 2-year position, with a possibility of extension. A 6-month trial period will be applied. The salary will be based on the University salary scheme for research and teaching staff (OV02 of the demands level table for teaching and research personnel in the salary system of Finnish universities, ca. 2 470 euros/month). The University of Helsinki offers comprehensive services to its employees, including occupational health care and health insurance, unemployment and pension fund, a generous holiday package, sports facilities, and opportunities for professional development: https://www.helsinki.fi/en/about-us/careers.
How to apply
Applications should be submitted through the University of Helsinki Recruitment System via the "Apply Now" button. Internal applicants (i.e., current employees of the University of Helsinki) submit their applications by using the “Employee Login” button.
Please send your application with following enclosures. When preparing your application, please indicate if AI is used in drafting any parts (if yes, which parts) and pay close attention to page limit and name the documents as indicated below with your last name and first name. Please, do not provide any other documents except for these:
- Cover letter describing your research interests, experience in bioinformatics and / or laboratory work and why you are an excellent candidate for this project (maximally one page, font 12 and line-spacing single; Cover_Lastname_Firstname).
- CV (with a possible list of publications; publications are not at all necessary and recently graduated / about to graduate applicants are encouraged to apply, maximally two pages, font 12 and line-spacing single; CV_Lastname_Firstname).
- Contact details of 2-3 references (References_Lastname_Firstname).
- Transcript of studies (BSc and MSc; BSc_Lastname_Firstname and MSc_Lastname_Firstname).
- Diplomas (Diploma_BSc_ Lastname_Firstname and Diploma_MSc_ Lastname_Firstname).
The closing date for applications is December 27th 2026 (please, submit your application prior to the deadline and remember that the days preceding the deadline are public holidays).
For further information on the position, please contact Harri Itkonen (harri.itkonen (at) helsinki.fi).
If you need technical support with the recruitment system, please contact HelsinkiUni Help, uni-help (at) helsinki.fi.
About us
The Faculty of Medicine promotes high-quality scientific research. It provides research-based undergraduate and postgraduate education in medicine, dentistry, psychology and logopedics, and an international Master's Programme in Translational Medicine. It also offers psychotherapist education. In addition to its teaching and research activities, the faculty serves as a significant expert organisation in the healthcare sector. For further information: https://www.helsinki.fi/en/faculty-of-medicine.
The Faculty of Medicine at the University of Helsinki constitutes the academic medical center together with HUS Helsinki University Hospital and the Helsinki Institute of Life Science (HiLIFE). This medical center has been successful in international comparisons, ranking among the top 10 medical campuses in Europe and the top 50 globally.
A diverse and equitable study and work culture is important to us. That is why we do our best to promote an inclusive university community. We encourage all qualified applicants from diverse backgrounds to apply for our positions.
Click this link to read about accessibility and inclusivity at our University.
JOIN US TO BUILD A BETTER WORLD – TOGETHER!
#HelsinkiUniCareers